Review: taking Neurontin and Subutex together


Summary

Drug interactions are reported among people who take Neurontin and Subutex together. This review analyzes the effectiveness and drug interactions between Neurontin and Subutex. It is created by eHealthMe based on reports of 201 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Neurontin and Subutex >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Neurontin

Neurontin has active ingredients of gabapentin. It is often used in pain. (latest outcomes from Neurontin 56,882 users)

Subutex

Subutex has active ingredients of buprenorphine hydrochloride. It is often used in drug dependence. (latest outcomes from Subutex 3,050 users)

On Jul, 26, 2016

201 people who take Neurontin, Subutex are studied.


Number of reports submitted per year:

Neurontin and Subutex drug interactions.

Drug effectiveness over time:

Neurontin:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Subutex:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 66.0% - (2 of 3 people)
  • 2 - 5 years: 100.0% - (2 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Neurontin:
  • female: 0.0% - (0 of 4 people)
  • male: 0.0% - (0 of 4 people)
Subutex:
  • female: 60.0% - (3 of 5 people)
  • male: 75.0% - (3 of 4 people)

Drug effectiveness by age:

Neurontin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 2 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 5 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Subutex:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 50.0% - (1 of 2 people)
  • 30-39: 100.0% - (2 of 2 people)
  • 40-49: 75.0% - (3 of 4 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • confusional state
  • malignant neoplasm progression
  • dizziness
  • ankle fracture
  • coagulopathy
  • disorientation
  • disturbance in attention
  • encephalopathy
  • fall
  • intestinal infarction
1 - 6 months:
  • acne
  • ankle fracture
  • colon cancer
  • confusional state
  • death
  • disorientation
  • disturbance in attention
  • encephalopathy
  • fall
  • malaise
6 - 12 months:
  • anxiety
  • headaches
1 - 2 years:
  • compulsions
  • drowsiness
  • fatigue
  • insomnia
  • loss of appetite
  • therapeutic response unexpected
  • uncontrollable urination
2 - 5 years:
  • hepatic encephalopathy
  • hepatic failure
  • chills
  • oedema
  • pyrexia
  • confusional state
  • sweating - excessive
  • anxiety
  • coagulation factor v level decreased
  • coma
not specified:
  • pain
  • dizziness
  • nausea
  • anxiety
  • vomiting
  • eye pain
  • pyrexia
  • fall
  • cardiac failure congestive
  • hypoaesthesia

Most common drug interactions by gender *:

female:
  • dizziness
  • pain
  • anxiety
  • insomnia
  • pyrexia
  • cardiac failure congestive
  • mouth ulceration
  • pain in extremity
  • accidental overdose
  • arthralgia
male:
  • nausea
  • depression
  • drug withdrawal syndrome
  • vomiting
  • corneal ulcer
  • headache
  • hyperbilirubinaemia
  • keratitis
  • paraesthesia
  • dehydration

Most common drug interactions by age *:

20-29:
  • acne
  • dizziness
  • dyspnoea
  • hypoaesthesia
  • loss of consciousness
  • mood altered
  • oedema peripheral
  • pain
  • suicidal ideation
  • vertigo
30-39:
  • headache
  • depression
  • corneal ulcer
  • hyperbilirubinaemia
  • keratitis
  • paraesthesia
  • eyelid ptosis
  • oral candidiasis
  • scab
  • bronchitis
40-49:
  • nausea
  • complex regional pain syndrome
  • depression
  • headache
  • hyperhidrosis
  • hypotension
  • thermal burn
  • vomiting
  • weight increased
  • abdominal pain
50-59:
  • anxiety
  • fall
  • insomnia
  • accidental overdose
  • arthralgia
  • bone disorder
  • cardiac failure congestive
  • chondromalacia
  • deformity
  • dizziness
60+:
  • somnolence
  • pneumonia aspiration
  • vomiting
  • dehydration
  • nausea
  • anaemia
  • confusional state
  • nerve root compression
  • drug withdrawal syndrome
  • dizziness

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Neurontin and Subutex?


Recent conversations of related support groups:

Can you answer these questions?

More questions for: Neurontin, Subutex

You may be interested in these reviews

More reviews for: Neurontin, Subutex

On eHealthMe, Neurontin (gabapentin) is often used to treat pain. Subutex (buprenorphine hydrochloride) is often used to treat drug dependence. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.